These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1334183)

  • 41. The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan.
    Yang SE; Pan MJ; Tseng HF; Liau MY
    Vaccine; 2006 Mar; 24(14):2669-73. PubMed ID: 16314007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Undesirable reactions of domestic pigeons to vaccination against paramyxovirus type 1.
    Bönner BM; Koehler K; Reichel U; Beck I; Jaeger S; Barbeito J; Redmann T; Kaleta EF
    Dtsch Tierarztl Wochenschr; 2003 Oct; 110(10):403-6. PubMed ID: 14650734
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The efficacy of Japanese encephalitis vaccine in Henan, China: a case-control study.
    Luo D; Yin H; Xili L; Song J; Wang Z
    Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):643-6. PubMed ID: 7667706
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A field trial of Japanese encephalitis vaccine produced in Thailand.
    Rojanasuphot S; Charoensuk O; Kitprayura D; Likityingvara C; Limpisthien S; Boonyindee S; Jivariyavej V; Ugchusak K
    Southeast Asian J Trop Med Public Health; 1989 Dec; 20(4):653-4. PubMed ID: 2561722
    [No Abstract]   [Full Text] [Related]  

  • 45. Immunization for children traveling abroad.
    Sood SK
    Pediatr Clin North Am; 2000 Apr; 47(2):435-48, viii. PubMed ID: 10761513
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Japanese encephalitis vaccine for travelers: exploring the limits of risk.
    Shlim DR; Solomon T
    Clin Infect Dis; 2002 Jul; 35(2):183-8. PubMed ID: 12087525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Japanese encephalitis: report of a World Health Organization Working Group.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1984 Mar; 33(9):119-20, 125. PubMed ID: 6321941
    [No Abstract]   [Full Text] [Related]  

  • 48. [Travel vaccination].
    Sandbu S
    Tidsskr Nor Laegeforen; 2006 Nov; 126(21):2810-3. PubMed ID: 17086222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single dose of inactivated Japanese encephalitis vaccine with poly(gamma-glutamic acid) nanoparticles provides effective protection from Japanese encephalitis virus.
    Okamoto S; Yoshii H; Ishikawa T; Akagi T; Akashi M; Takahashi M; Yamanishi K; Mori Y
    Vaccine; 2008 Jan; 26(5):589-94. PubMed ID: 18180081
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of complete adjuvant on vaccination of live attenuated Japanese encephalitis vaccine to swine for preventing viremia. 39. Epidemiological studies of J.E.
    Ogata M; Nagao Y; Kikui R; Kitamura N; Ariyasu H
    Acta Med Okayama (1952); 1971; 25(1):71-5. PubMed ID: 4334469
    [No Abstract]   [Full Text] [Related]  

  • 51. [Vaccination against bluetongue serotype 8 in the Netherlands].
    Kuijk H; Jansen M; Moulin V; Makoschey B
    Tijdschr Diergeneeskd; 2008 Dec; 133(23):1006-9. PubMed ID: 19133439
    [No Abstract]   [Full Text] [Related]  

  • 52. [Japanese B encephalitis--incidence, clinical picture and prevention in travelers to Eastern Asia].
    Stenbeck JL
    Lakartidningen; 1979 Aug; 76(35):2893-5. PubMed ID: 228131
    [No Abstract]   [Full Text] [Related]  

  • 53. A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis.
    Lyons A; Kanesa-thasan N; Kuschner RA; Eckels KH; Putnak R; Sun W; Burge R; Towle AC; Wilson P; Tauber E; Vaughn DW
    Vaccine; 2007 Apr; 25(17):3445-53. PubMed ID: 17241714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurological complications and Japanese encephalitis vaccination.
    Plesner AM; Arlien-Søborg P; Herning M
    Lancet; 1996 Jul; 348(9021):202-3. PubMed ID: 8684185
    [No Abstract]   [Full Text] [Related]  

  • 55. Control of Japanese encephalitis in Japan: immunization of humans and animals, and vector control.
    Igarashi A
    Curr Top Microbiol Immunol; 2002; 267():139-52. PubMed ID: 12082987
    [No Abstract]   [Full Text] [Related]  

  • 56. Vaccination against bluetongue: new rules in the pipeline.
    Vet Rec; 2011 Apr; 168(15):393. PubMed ID: 21498445
    [No Abstract]   [Full Text] [Related]  

  • 57. Liability for vaccine-related injuries.
    Marcus LC
    N Engl J Med; 1988 Jan; 318(3):191-2. PubMed ID: 2827027
    [No Abstract]   [Full Text] [Related]  

  • 58. Immunisation against Japanese encephalitis.
    Bonington A; Harbord M; Davidson RN; Cropley I; Behrens RH
    Lancet; 1995 Jun; 345(8962):1445-6. PubMed ID: 7760642
    [No Abstract]   [Full Text] [Related]  

  • 59. Japanese Encephalitis in China in the Period of 1950-2018: From Discovery to Control.
    Chen XJ; Wang HY; Li XL; Gao XY; Li MH; Fu SH; He Y; Li F; Yin QK; Xu ST; Wu D; Li YX; Yin ZD; Yang G; Liang GD
    Biomed Environ Sci; 2021 Mar; 34(3):175-183. PubMed ID: 33766213
    [No Abstract]   [Full Text] [Related]  

  • 60. Two patterns of systemic immediate-type reactions to Japanese encephalitis vaccines.
    Sakaguchi M; Inouye S
    Vaccine; 1998 Jan; 16(1):68-9. PubMed ID: 9607011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.